-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Lowers Price Target to $21

Benzinga·02/25/2026 15:40:01
Listen to the news
Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and lowers the price target from $40 to $21.